SCAI statement on ad hoc versus the separate performance of diagnostic cardiac catheterization and coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 63, Issue 4, 2004, Pages 444-451

  Blankenship, James C ^a   Klein, Lloyd W ^b   Laskey, Warren K ^c   Krone, Ronald J ^d   Dehmer, Gregory J ^e   Chambers, Charles ^f   Cowley, Michael ^g  

^a GEISINGER MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEXAS A M COLLEGE OF MEDICINE   (United States)

^f PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Costs; Stenting

Indexed keywords

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; BRACHYTHERAPY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; COST CONTROL; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INFORMED CONSENT; KIDNEY FAILURE; MORTALITY; PATIENT SELECTION; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOLOGY; CLINICAL TRIALS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEART CATHETERIZATION; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES; RISK ASSESSMENT; SOCIETIES, MEDICAL;

EID: 9644289534     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20229     Document Type: Review

References (38)

1. Feldman RL, Macdonald RG, Hill JA, Conti R, Pepine CJ, Carmichael MJ, Knauff DG, Alexander JA. Coronary angioplasty at the time of initial cardiac catheterization. Cathet Cardiovasc Diagn 1986;12:219-222.
2. Myler RK, Stertzer SH, Clark DA, Shaw RE, Fishman-Rosen J, Murphy MC. Coronary angioplasty at the time of initial cardiac catheterization. Cathet Cardiovasc Diagn 1986;12:213-214.
3. Haraphongse M, Tymchak W, Rossal RE. Coronary angioplasty at the time of initial diagnostic coronary angiography in patients with unstable angina. Cathet Cardiovasc Diagn 1988;14:73-75.
4. O'Keefe JH, Reeder GS, Miller GA, Bailey KR, Holmes DR. Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic catheterization compared with that performed at other times. Am J Cardiol 1989;63:27-29.
5. Breisblatt WM, Ruffner RJ, Uretsky BF, Reddy PS. Same-day angioplasty and diagnostic catheterization: safe and effective but riskier in unstable angina. Angiology 1991;8:607-613.
6. O'Keefe JH, Gernon C, McCallister BD, Ligon RW, Hartzier GO. Safety and cost effectiveness of ad hoc coronary angiography and angioplasty. Am Heart J 1991;122:50-54.
7. Lund GK, Nienaber CA, Hamm CW, Terres W, Kuck KH. One session diagnostic heart catheterization and balloon dilatation ("prima-vista"-PTCA): results and risks. Deutsche Medizinische Wochenschrift 1994;119:169-174.
8. Rozenman Y, Gilon D, Zelingher J, Lotan C, Mosseri M, Geist M, Weiss AT, Hasin Y, Gotsman MS. One-stage coronary angiography and angioplasty. Am J Cardiol 1995;75:30-33.
9. Kimmel SE, Berlin JE, Hennessy S, Strom BL, Krone RJ, Laskey WK. Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography: results from the Registry of the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1997;30:193-200.
10. Blankenship JC, Mishkel G, Chambers CE, Hodgson JM, Holmes DR, Sheldon W, Schweiger MJ, Cowley MJ, Popma JJ. Ad hoc coronary angioplasty: a position paper of the Society for Cardiac Angiography and Intervention. Catheter Cardiovasc Interv 2000;491:30-134.
11. Adele C, Vaitkus PL, Wells SK, Zehnacker JB. Cost advantages of an ad hoc angioplasty strategy. J Am Coll Cardiol 1998;31:321-325.
12. Shubrooks SJ, Malenka DJ, Piper WD, Bradley WA, Watkins MW, Ryan TJ, Hettleman BD, VerLee PN, O'Meara JR, Robb JF, Kellett MA, Hearne MA, McGrath PD, Wennberg DE, O'Rourke DJ, Silver TM. Safety and efficacy of percutaneous coronary interventions performed immediately after diagnostic catheterization in northern New England and comparison with similar procedures performed later. Am J Cardiol 2000;86:41-45.
13. Goldstein CL, Racz M, Hannan EL. Impact of cardiac catheterization- percutaneous coronary intervention timing on in-hospital mortality. Am Heart J 2002;144:561-567.
14. Lane DM. Ad hoc angiography: angioplasty may not be safe, easier on the patient, or more cost-effective. Am J Cardiol 1995;76:641.
15. Hill JA. Single-stage coronary angiography and angiopasty: a new standard? Am J Cardiol 1995;75:75-76.
16. Rozenman Y, Gotsman MS, Penchas S. Single-stage coronary angiography and angioplasty: a new standard. Am J Cardiol 1999;76:1321.
17. Reeves TJ, Williams DO, Winters WL. Guidelines for percutaneous transluminal coronary angioplasty. Circulation 1988;78:486-502.
18. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, McAllister BD, Smith SC, Ullyot DJ. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22:2033-2054.
19. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Keriakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/ AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Associaton Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239.
20. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, Schmitt C, Seyfarth M, Dirschinger J, Schomig A. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003;290:1593-1599.
21. Singh M, Rihal CS, Selzer F, Kip KE, Detre K, Holmes DR. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute Dynamic Registry. J Am Coll Cardiol 2003;42:1722-1728.
22. Shaw RE, Anderson HV, Brindis RG, Krone RJ, Klein LW, McKay CR, Block PC, Shaw LJ, Hewitt K, Weintraub WS. Updated risk adjustment mortality model using the complete 1.1 dataset from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR). J Invas Cardiol 2003;15:578-580.
23. Qureshi MA, Safian RD, Grines CL, Goldstein JA, Westveer DC, Glazier S, Balasubramanian M, O'Neill WW. Simplified scoring system for predicting mortality after percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1890-1895.
24. Krone RJ, Laskey WK, Johnson C, Kimmel SE, Klein LW, Weiner BH, Cosentino JJ, Johnson SA, Babb JD. A simplified lesion classification for predicting success and complications of coronary angioplasty: Registry Committee of the Society for Cardiac Angiography and Intervention. Am J Cardiol 2000;85:1179-1184.
25. Krone RJ, Kimmel SE, Laskey WK, Klein LW, Schechtman KB, Cosentino JJ, Babb JD, Weiner BH. Registry Committee of the Society for Cardiac Angiography and Interventions: evaluation of the Society for Coronary Angiography and Interventions' lesion classification system in 14,133 patients with percutaneous coronary interventions in the current stent era. Catheter Cardiovasc Interv 2002;55:1-7.
26. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
27. Tommaso CL. Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization. Cathet Cardiovasc Diagn 1994;31:316-321.
28. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude F, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362:598-603.
29. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003;349:1333-1340.
30. DeLuca SA, Korcuska LA, Oberstar BH, Rosenthal ML, Welsh PA, Topol EJ. Are we promoting true informed consent in cardiovascular clinical trials? J Cardiovasc Nurs 1995;9:54-61.
31. Steinhubl SR, Ellis SG, Wolski K, Lincoff AM, Topol EJ. Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial. Circulation 2001;103:1403-1409.
32. Chan AW, Moliterno DJ, Berger PB, Stone GW, DiBattiste PM, Yakubov SL, Sapp SK, Wolski K, Bhatt DL, Topol EJ. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival. J Am Coll Cardiol 2003;42:1188-1195.
33. Steinhubl SR, Berer PR, Mann JT, Fry ETA, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. JAMA 2002;288:2411-2420.
34. Kastrati A, Mehilli J, Schuhlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann F-J, Bollwein H, Volmer C, Gawaz M, Berger PB, Schomig A. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350:232-238.
35. Hodgson JMcB. The dilemma. Catheter Cardiovasc Interv 2004;61:153-155.
36. Fearon WF, Yeung AC. Evaluating intermediate coronary lesions in the cardiac catheterization laboratory. Rev Cardiovasc Med 2003;4:1-7.
37. Blankenship JC. Ethics in interventional cardiology: combining coronary intervention with diagnostic catheterization. Am Heart Hosp 2004;2:52-54.
38. Beauchamp TL, Childress JF. Principles of biomedical ethics. New York: Oxford University Press; 1989.